Skip to main content

Sign up for our newsletter.

Quality journalism. Progressive values. Direct to your inbox.

For Immediate Release

Press Release

Shameful Sackler Settlement Exploits Bankruptcy Rules to Immunize Purdue Owners, Execs

WASHINGTON -

A U.S. judge today approved OxyContin maker Purdue Pharma’s bankruptcy reorganization plan, which will shield the company’s Sackler family owners from future litigation over the opioid crisis. Valued at more than $10 billion, this plan would immunize the Sackler family and Purdue Pharma from thousands of opioid lawsuits. Rick Claypool, a research director for Public Citizen, released the following statement:

“Allowing the billionaires at the root of the opioid crisis to walk free while thousands of its victims are in prison is a catastrophic injustice.

“Purdue Pharma is the reason the Sackler family are billionaires, and after today’s settlement they will remain billionaires. The greed of some Sacklers fueled an opioid epidemic that has killed more than 500,000 Americans, gripped millions in the claws of addiction, devastated communities across the country, and cost over $2.5 trillion.

“Meanwhile, on any given day, 450,000 incarcerated people are serving time for nonviolent drug crimes.

“The Biden administration has the authority to pursue leniency for nonviolent drug offenders, whose unnecessary and cruel incarceration must be replaced with support to help communities heal the raw wounds the opioid epidemic left behind. The administration also has the authority to continue the last administration’s criminal investigation and indict any member of the Sackler family who committed crimes while pursuing opioid profits. On both fronts, the administration should exercise its authority without delay.”

###

Public Citizen is a nonprofit consumer advocacy organization that champions the public interest in the halls of power. We defend democracy, resist corporate power and work to ensure that government works for the people – not for big corporations. Founded in 1971, we now have 500,000 members and supporters throughout the country.

One Year In, Biden Fails to Boost C- Grade on Environment

The Center for Biological Diversity Action Fund assessment indicates the administration's action to deliver on environmental promises "desperately needs improvement."

Jessica Corbett ·


'A No-Brainer': Lawmakers Urge Pelosi to Hold Vote on Stock Trading Ban

"Perhaps this means some of our colleagues will miss out on lucrative investment opportunities," said House members in a bipartisan letter. "We don't care."

Jessica Corbett ·


Virginia Schools Sue Youngkin Mandate Making Masks Optional

The Republican governor wants to allow parents to decide whether their children should wear masks to school to mitigate Covid-19 transmission—guidance at least 58 school districts have no plans to follow.

Julia Conley ·


US Puts Troops on Standby as War Tensions Over Ukraine Mount

The U.K. threatens "lightning war" as military forces mobilize in eastern Europe.

Andrea Germanos ·


Advocacy Group Urges Pfizer to Combat Paxlovid Inequality

"Help end the pandemic this year around the world," one advocate told Pfizer. "Not just in a handful of rich countries."

Kenny Stancil ·

Support our work.

We are independent, non-profit, advertising-free and 100% reader supported.

Subscribe to our newsletter.

Quality journalism. Progressive values.
Direct to your inbox.

Subscribe to our Newsletter.


Common Dreams, Inc. Founded 1997. Registered 501(c3) Non-Profit | Privacy Policy
Common Dreams Logo